The pharmacogenetics pharmacy residency is one of only two ASHP-accredited pharmacogenetics programs in the nation. Directed by Kristin Wiisanen, Pharm.D., FAPhA, a clinical professor of pharmacotherapy and translational research and associate director of UF Health’s Precision Medicine Program, the residency focuses on implementing pharmacogenetics into clinical practice. Residents in their second-year of postgraduate training gain valuable experience to prepare them for careers in academia, clinical practice or industry.
The pharmacogenetics resident works closely with the Wiisanen and plays a central role in the clinical implementation of pharmacogenetic services and the literature evaluation and review process for the Precision Medicine Program Subcommittee of the Pharmacy and Therapeutics Committee. This committee makes all recommendations regarding clinical implementation of pharmacogenetics, including defining the content of pharmacogenetic electronic health record alerts and drug therapy alternatives. The resident also has an important role in educating clinicians about pharmacogenetics, and clinical responsibilities in ensuring the appropriate use of pharmacogenetic information in patients.
For questions about the residency, please contact: Kristin Wiisanen, Pharm.D., FAPhA